Interobserver variability in organ at risk delineation in head and neck cancer.

Auteurs : van der Veen J, Gulyban A, Willems S, Maes F, Nuyts S
Année : 2021
Journal : Radiat Oncol
Volume : 16
Pages : 120

VISTA: A Promising Target for Cancer Immunotherapy?

Auteurs : Tagliamento M, Agostinetto E, Borea R, Brandão M, Poggio F, Addeo A, Lambertini M
Année : 2021
Journal : Immunotargets Ther
Volume : 10
Pages : 185-200

The NHance^® Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer Patients.

Auteurs : Aftimos P, Rolfo C, Rottey S, Barthélémy P, Borg C, Park K, Oh DY, Kim SW, De Jonge N, Hanssens V, Zwanenpoel K, Molthoff C, Vugts D, Dreier T, Verheesen P, van Dongen GAMS, Jacobs J, Van Rompaey L, Hultberg A, Michieli P, Pauwels P, Fung S, Thibault A, de Haard H, Leupin N, Awada A
Année : 2021
Journal : Biomedicines
Volume : 9

HER2-Low Breast Cancer: Molecular Characteristics and Prognosis.

Auteurs : Agostinetto E, Rediti M, Piccart-Gebhart M, Fimereli D, Debien V, Aftimos P, Sotiriou C, de Azambuja E
Année : 2021
Journal : Cancers (Basel)
Volume : 13

Targeted radionuclide therapy: an emerging field in solid tumours.

Auteurs : Artigas C, Mileva M, Flamen P, Karfis I
Année : 2021
Journal : Curr Opin Oncol
Volume : 33
Pages : 493-499

Helminth infection induces non-functional sensitization to house dust mites.

Auteurs : Doyen V, Truyens C, Nhu Thi H, Mong HTT, Le Chi T, De Blay F, Huynh Thi, Michel O, Corazza F
Année : 2021
Journal : PLoS One
Volume : 16
Pages : e0253887

Emerging issues related to COVID-19 vaccination in patients with cancer.

Auteurs : Saini KS, Martins-Branco D, Tagliamento M, Vidal L, Singh N, Punie K, Saini ML, Chico I, Curigliano G, de Azambuja E, Lambertini M
Année : 2021
Journal : Oncol Ther
Pages : 1-11

A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol.

Auteurs : Michiels S, Tricas-Sauras S, Dauvrin M, Bron D, Kirakoya-Samadoulougou F
Année : 2021
Journal : PLoS One
Volume : 16
Pages : e0253526

Risk-based decision-making in the treatment of HER2-positive early breast cancer: Recommendations based on the current state of knowledge.

Auteurs : Jackisch C, Cortazar P, Geyer CE Jr, Gianni L, Gligorov J, Machackova Z, Perez EA, Schneeweiss A, Tolaney SM, Untch M, Wardley A, Piccart-Gebhart M
Année : 2021
Journal : Cancer Treat Rev
Volume : 99
Pages : 102229

The clinicopathologic spectrum and genomic landscape of de-/trans-differentiated melanoma.

Auteurs : Ferreira I, Droop A, Edwards O, Wong K, Harle V, Habeeb O, Gharpuray-Pandit D, Houghton J, Wiedemeyer K, Mentzel T, Billings SD, Ko JS, Füzesi L, Mulholland K, Prusac IK, Liegl-Atzwanger B, de Saint Aubain N, Caldwell H, Riva L, van der Weyden L, Arends MJ, Brenn T, Adams DJ
Année : 2021
Journal : Mod Pathol
Volume : 34
Pages : 2009-2019

Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry.

Auteurs : Hernández-Boluda JC, Pereira A, Kröger N, Cornelissen JJ, Finke J, Beelen D, de Witte M, Wilson K, Platzbecker U, Sengeloev H, Blaise D, Einsele H, Sockel K, Krüger W, Lenhoff S, Salaroli A, Martin H, García-Gutiérrez V, Pavone V, Alvarez-Larrán A, Raya JM, Zinger N, Gras L, Hayden P, Czerw T, P McLornan D, Yakoub-Agha I
Année : 2021
Journal : Am J Hematol
Volume : 96
Pages : 1186-1194

Complete response and renal cell carcinoma in the immunotherapy era: The paradox of good news.

Auteurs : Zambrana F, Carril-Ajuria L, Gómez de Liaño A, Martinez Chanza N, Manneh R, Castellano D, de Velasco G
Année : 2021
Journal : Cancer Treat Rev
Volume : 99
Pages : 102239

A Late Dermatologic Presentation of Bullous Pemphigoid Induced by Anti-PD-1 Therapy and Associated with Unexplained Neurological Disorder.

Auteurs : Wang X, Suppa M, Bruderer P, Sirtaine N, Aspeslagh S, Kerger J
Année : 2021
Journal : Case Rep Oncol
Volume : 14
Pages : 861-867

European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer.

Auteurs : Partelli S, Sclafani F, Barbu ST, Beishon M, Bonomo P, Braz G, de Braud F, Brunner T, Cavestro GM, Crul M, Trill MD, Ferollà P, Herrmann K, Karamitopoulou E, Neuzillet C, Orsi F, Seppänen H, Torchio M, Valenti D, Zamboni G, Zins M, Costa A, Poortmans P
Année : 2021
Journal : Cancer Treat Rev
Pages : 102208

Correction to: Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failure.

Auteurs : Lemiale V, Dumas G, Demoule A, Pène F, Kouatchet A, Bisbal M, Nseir S, Argaud L, Kontar L, Klouche K, Barbier F, Seguin A, Louis G, Constantin JM, Mayaux J, Wallet F, Peigne V, Girault C, Oziel J, Nyunga M, Terzi N, Bouadma L, Lautrette A, Bige N, Raphalen JH, Papazian L, Bruneel F, Lebert C, Benoit D, Meert AP, Jaber S, Mokart D, Darmon M, Azoulay E
Année : 2021
Journal : Ann Intensive Care
Volume : 11
Pages : 105

Microbiome as Mediator of Diet on Colorectal Cancer Risk: The Role of Vitamin D, Markers of Inflammation and Adipokines.

Auteurs : Serrano D, Pozzi C, Guglietta S, Fosso B, Suppa M, Gnagnarella P, Corso F, Bellerba F, Macis D, Aristarco V, Manghi P, Segata N, Trovato C, Zampino MG, Marzano M, Bonanni B, Rescigno M, Gandini S
Année : 2021
Journal : Nutrients
Volume : 13

Discovery and 3D imaging of a novel ?Np63-expressing basal cell type in human pancreatic ducts with implications in disease.

Auteurs : Martens S, Coolens K, Van Bulck M, Arsenijevic T, Casamitjana J, Fernandez Ruiz A, El Kaoutari A, Martinez de Villareal J, Madhloum H, Esni F, Heremans Y, Leuckx G, Heimberg H, Bouwens L, Jacquemin P, De Paep DL, Int Veld P, DHaene N, Bouchart C, Dusetti N, Van Laethem JL, Waelput W, Lefesvre P, Real FX, Rovira M, Rooman I
Année : 2021
Journal : Gut

Response to letter entitled: Re: Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials.

Auteurs : Agostinetto E, Ceppi M, Bruzzone M, Lambertini M, de Azambuja E
Année : 2021
Journal : Eur J Cancer
Volume : 155
Pages : 303-306

Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy.

Auteurs : Jerusalem G, Farah S, Courtois A, Chirgwin J, Aebi S, Karlsson P, Neven P, Hitre E, Graas MP, Simoncini E, Abdi E, Kamby C, Thompson A, Loibl S, Gavilá J, Kuroi K, Marth C, Müller B, OReilly S, Gombos A, Ruhstaller T, Burstein HJ, Rabaglio M, Ruepp B, Ribi K, Viale G, Gelber Rd, Coates AS, Loi S, Goldhirsch A, Regan MM, Colleoni M
Année : 2021
Journal : Ann Oncol
Volume : 32
Pages : 1256-1266

MiR-7-5p inhibits thyroid cell proliferation by targeting the EGFR/MAPK and IRS2/PI3K signaling pathways.

Auteurs : Augenlicht A, Saiselet M, Decaussin-Petrucci M, Andry G, Dumont JE, Maenhaut C
Année : 2021
Journal : Oncotarget
Volume : 12
Pages : 1587-1599